Welcome to our dedicated page for SS Innovations SEC filings (Ticker: SSII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating regulatory nuggets about the SSi Mantra surgical robotic system inside a 300-page filing is tedious. SS Innovations鈥� disclosures span R&D spending for new cardiac instruments, global regulatory milestones, and surgeon adoption metrics鈥攍ayers of detail that can slow decision-making.
Stock Titan solves that problem. Our AI reads every SS Innovations quarterly earnings report 10-Q filing, flags changes in production costs, and translates medical-device jargon into plain language. Wondering about SS Innovations insider trading Form 4 transactions? Receive real-time alerts the moment executives trade shares, complete with context you can understand in seconds. From the latest SS Innovations annual report 10-K simplified to a sudden SS Innovations 8-K material events explained, every document arrives on your screen as soon as it hits EDGAR鈥攁lready summarized.
Use cases investors rely on daily:
- Compare R&D outlays across robotic platforms with our AI-driven 10-K analysis
- Track SS Innovations executive stock transactions Form 4 before product-launch announcements
- Review surgeon-training commitments buried in the proxy鈥�SS Innovations proxy statement executive compensation details included
Whether you need SS Innovations SEC filings explained simply or deep SS Innovations earnings report filing analysis, our platform delivers comprehensive coverage鈥�10-Ks, 10-Qs, 8-Ks, S-1s, and more鈥攑aired with clear, AI-powered insights so you can act with confidence.
What happened: SS Innovations reported strong sales growth this quarter and in the first half of 2025, driven by system and instrument sales. Total revenue for the quarter was $10.0M and for the first six months $15.1M. Gross profit rose and operating results improved to a small positive operating income for the quarter, and the company completed an uplisting to NASDAQ.
Why it matters: The company boosted cash to $17.6M after financings and conversions, which helps near-term operations, but it still reported a $5.94M net loss for the first half and a small quarterly net loss after tax. Management discloses substantial doubt about the company鈥檚 ability to continue as a going concern and notes dependence on related-party financing and convertible note conversions.
SS Innovations International, Inc. (Nasdaq: SSII) filed a Form 8-K dated 15 July 2025 to disclose an operational milestone. The company reports that it has now installed more than 100 SSi Mantra surgical robotic systems across India and six other countries. Collectively, the installed base has facilitated over 5,000 surgical procedures, including 240 cardiac surgeries and 32 telesurgeries.
The filing contains no revenue, earnings, guidance or transactional information; it simply furnishes the related press release as Exhibit 99.1. While financial details are absent, the figures provided highlight growing clinical adoption and an expanding geographic presence for the Mantra platform.
SS Innovations International, Inc. (SSII) filed an amended Form 4 for Director and COO-Americas Barry F. Cohen. The amendment corrects the total share count after three small open-market purchases:
- 100 shares at $8.75 on 04/17/2025
- 100 shares at $8.90 on 04/22/2025
- 226 shares at $9.00 on 04/22/2025
The transactions add 426 shares in total, bringing Cohen鈥檚 directly held position to 8,866,888 common shares. No derivative securities were involved. The filing states the prior Form 4 contained an inadvertent misstatement of holdings, which is now rectified. While the dollar value of the purchases is modest, insider buying鈥攅specially by a director/officer鈥攃an be interpreted as a signal of confidence. However, the tiny size relative to Cohen鈥檚 existing 8.87 million-share stake limits financial materiality.
FAQ
What is the current stock price of SS Innovations (SSII)?
What is the market cap of SS Innovations (SSII)?
